Acefylline (INN),[1] also known as 7-theophyllineacetic acid, is a stimulant drug of the xanthine chemical class. It acts as an adenosine receptor antagonist. It is combined with diphenhydramine in the pharmaceutical preparation etanautine to help offset diphenhydramine induced drowsiness.[2]
 | |
 | |
| Clinical data | |
|---|---|
| Routes of administration | Intramuscular, Intravenous |
| ATC code | |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.010.447  |
| Chemical and physical data | |
| Formula | C9H10N4O4 |
| Molar mass | 238.203 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Asilanol–mannuronic acid conjugate of acefylline, acefylline methylsilanol mannuronate (INCI; trade name Xantalgosil C) is marketed as a lipolytic phosphodiesterase inhibitor. It is used as an ingredient in cosmeceuticals for the treatment of cellulite and as a skin conditioner.[3][4]
{{cite journal}}: Cite journal requires |journal= (help)
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |